2016.09.27 Press Release
top of page

ASTROTECH REPORTS FIRST QUARTER OF FISCAL YEAR 2017 FINANCIAL RESULTS

- Total Revenue of $1.0 million -

- 1st Detect Patent Strengthens IP Portfolio -

Austin, TX (November 10, 2016) - 
 

Astrotech Corporation (NASDAQ: ASTC) reported its financial results for the first quarter of fiscal year 2017, ended September 30, 2016.

 

“The foundational achievements of fiscal year 2016 drove our continued progress on our government-related subcontract agreements to $1.0 million in revenue for our first quarter of fiscal 2017,” said Thomas B. Pickens III, Chairman and CEO of Astrotech Corporation. “Our 1st Detect subsidiary delivered milestones for a key government contract to develop next-generation explosive trace detection (ETD) systems for aviation security and began preparing to deliver multiple prototype units for integration into Battelle’s Next Generation Chemical Detection (NGCD) prototype solution. We believe these two achievements continue to bolster future sales prospects for 1st Detect, while cost reductions implemented in July helped the bottom line. Also, we remain actively engaged with our commercial development partners for application specific chemical detection solutions for opportunities in healthcare, breath analysis, food and beverage manufacturing quality control.”

 

“Our Astral Images subsidiary continues to receive very positive results from critical evaluations by leading studios of its revolutionary automated image correction and enhancement technology. With more than 6 billion feet of film in the US needing conversion to remain relevant in the next generation of digital distribution, we are pursuing the most attractive opportunities.”

 

“In summary, we continue to create value with our technological innovations and protect the unique advantages of our products with a strong IP portfolio,” concluded Mr. Pickens.

 

First Quarter Fiscal Year 2017 Financial Highlights

Revenue, costs of goods sold, SG&A, and R&D are expected to continue to fluctuate based on the timing of contract revenue.

 

  • During the first quarter 2017, revenue was $1.0 million, reflecting 1st Detect’s income from research-based, fixed-price, government-related subcontracts.

  • Gross profit was $275 thousand for the first quarter 2017.

  • Corporate realignment is expected to save the Company approximately $3.5 million for the year.

  • Cash and investments at September 30, 2016 were $22.3 million; there was no debt for each of the periods ended September 30, 2016 and June 30, 2016.

  • Granted one additional U.S. patent and one international patent during the first quarter 2017, bringing the total to 17 U.S. patents and seven international patents.

 

About Astrotech Corporation

Astrotech Corporation (NASDAQ: ASTC) is an innovative science and technology development and commercialization company that invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions, and then funds, manages, and builds start-up companies for profitable divestiture to market leaders to maximize shareholder value. Sourced from Oak Ridge Laboratory’s chemical analyzer research, 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, food and beverage, research, and breath analysis markets. Sourced from decades of image research from the laboratories of IBM and Kodak combined with classified satellite technology from government laboratories, Astral Images sells film to digital image enhancement, defect removal and color correction software, and post processing services providing economically feasible conversion of television and feature 35mm and 16mm films to the new 4K ultra-high definition (UHD), high-dynamic range (HDR) format necessary for the new generation of digital distribution. Sourced from NASA’s extensive microgravity research, Astrogenetix is applying a fast-track on-orbit discovery platform using the International Space Station to develop vaccines and other therapeutics. Demonstrating its entrepreneurial strategy, Astrotech management sold its state-of-the-art satellite servicing operations to Lockheed Martin in August 2014. Astrotech has operations throughout Texas and is headquartered in Austin. For information, please visit www.astrotechcorp.com.

 

This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These factors include, but are not limited to, whether we can successfully develop our proprietary technologies and whether the market will accept our products and services, as well as other risk factors and business considerations described in the Company’s Securities and Exchange Commission filings including the annual report on Form 10-K. Any forward-looking statements in this document should be evaluated in light of these important risk factors. The Company assumes no obligation to update these forward-looking statements.

 

Company Contact:

 

Eric Stober

Chief Financial Officer

Astrotech Corporation

(512) 485-9530
 

IR Contact:

 

Cathy Mattison and Kirsten Chapman

LHA Investor Relations

(415) 433-3777

ir@astrotechcorp.com

 

View PDF with Tables

bottom of page